<DOC>
	<DOCNO>NCT01744405</DOCNO>
	<brief_summary>The investigator propose study transfer nifurtimox breastmilk lactate woman receive drug treatment Chagas disease . Breastmilk blood sample obtain patient pre-specified time take clinically indicate medication , concentration matrix compare estimate degree transfer . Estimation nifurtimox transfer breastmilk allow evaluation potential degree exposure infant breastfed woman nifurtimox . This study help clarify safety continue breastfeed receive treatment nifurtimox Chagas disease .</brief_summary>
	<brief_title>Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease</brief_title>
	<detailed_description />
	<mesh_term>Chagas Disease</mesh_term>
	<mesh_term>Nifurtimox</mesh_term>
	<criteria>Lactating woman Chagas disease , treat Use contraception History allergy nifurtimox excipients Pregnancy Significant heart involvement ( due Chagas disease ) Significant systemic disease could affect interpretation result opinion principal investigator</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Chagas disease</keyword>
	<keyword>lactation</keyword>
	<keyword>breastmilk</keyword>
	<keyword>postpartum period</keyword>
	<keyword>infant</keyword>
	<keyword>pediatric clinical pharmacology</keyword>
	<keyword>developmental clinical pharmacology</keyword>
	<keyword>parasitology</keyword>
	<keyword>trypanosoma cruzi</keyword>
	<keyword>nifurtimox</keyword>
</DOC>